LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.95 | 84.90 | 999 | 4952 | 0.2017 | 0.5223 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.95 | 84.90 | 43 | 4952 | 0.0087 | -0.1095 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.95 | 84.90 | 972 | 4952 | 0.1963 | 0.5153 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.65 | 84.90 | 36 | 5328 | 0.0068 | -0.1338 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.65 | 84.90 | 967 | 5328 | 0.1815 | 0.5029 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.65 | 84.90 | 22 | 5328 | 0.0041 | -0.2024 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 48.65 | 84.90 | 926 | 5328 | 0.1738 | 0.4920 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.36 | 84.90 | 45 | 5651 | 0.0080 | -0.0995 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.36 | 84.90 | 978 | 5651 | 0.1731 | 0.4971 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.36 | 84.90 | 17 | 5651 | 0.0030 | -0.2332 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.36 | 84.90 | 895 | 5651 | 0.1584 | 0.4753 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.06 | 84.90 | 45 | 5990 | 0.0075 | -0.0982 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.06 | 84.90 | 1015 | 5990 | 0.1694 | 0.4979 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.06 | 84.90 | 5 | 5990 | 0.0008 | -0.3695 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.06 | 84.90 | 842 | 5990 | 0.1406 | 0.4530 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 84.90 | 38 | 6252 | 0.0061 | -0.1216 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 84.90 | 943 | 6252 | 0.1508 | 0.4743 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 84.90 | 4 | 6252 | 0.0006 | -0.3889 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 84.90 | 759 | 6252 | 0.1214 | 0.4236 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 84.90 | 40 | 6567 | 0.0061 | -0.1130 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 84.90 | 883 | 6567 | 0.1344 | 0.4525 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 84.90 | 1 | 6567 | 0.0002 | -0.5074 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 84.90 | 707 | 6567 | 0.1077 | 0.4020 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.18 | 84.90 | 28 | 6963 | 0.0040 | -0.1601 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.18 | 84.90 | 889 | 6963 | 0.1277 | 0.4469 | MN20160318_Q02 | J14 |